| 英文名称 |
中文名称 |
CAS |
|
Probucol impurity 2
|
普罗布考杂质2 |
|
|
Formyl-dioxetene
|
甲酰-二氧杂环戊二烯酮 |
91526-17-9 |
|
L-Glutamic Acid Eltogliptin Impurity 5
|
L-焦谷氨酸艾托格列净杂质5 |
333361-51-6 |
|
Mosapride Impurity 22
|
莫沙必利杂质22 |
|
|
(E)-2-Ethyl-2-hexenoic acid
|
(E)-2-乙基-2-己烯酸 |
5309-52-4 |
|
H-Aph(Hor)-OH
|
H-Aph(Hor)-OH对照品 |
2096508-06-2 |
|
Mosapride Impurity 12
|
莫沙必利杂质12 |
|
|
Argatroban Impurity 422-5G
|
阿加曲班杂质422-5G |
66937-88-0 |
|
Piperacillin Impurity K
|
哌拉西林杂质K |
|
|
5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine-7(8H)-carboxaldehyde
|
5,6-二氢-3-(三氟甲基)-1,2,4-三唑并[4,3-a]吡嗪-7(8H)-甲醛 |
1481965-39-2 |
|
6-((4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazol-3-yl)oxy)hex-2-ol
|
6-((4-(1-甲基-1,2,5,6-四氢吡啶-3-基)-1,2,5-噻二唑-3-基)氧基)己-2-醇 |
|
|
Oleanolic acid Imp1
|
齐墩果酸Imp1杂质 |
|
|
Alogliptin Benzoate Intermediate (AGLT-1)
|
苯甲酸阿格列汀中间体(AGLT-1)工作对照品 |
|
|
Rivaroxaban iMpurity V-4
|
利伐沙班杂质V-4 |
|
|
(1S,5R,E)-3-Ethyl-7-(nitromethylene)bicyclo[3.2.0]hept-2-ene
|
(1S,5R,E)-3-乙基-7-(硝基亚甲基)双环[3.2.0]庚-2-烯 |
|
|
Dasatinib Impurity HC1012-3022
|
达沙替尼杂质HC1012-3022 |
5053-43-0 |
|
3-Chloro-5-hydroxyBenzotrifluoride
|
3-氯-5-(三氟甲基)苯酚 |
570391-18-3 |
|
Atorvastatin Calcium Impurity O Reference Standard
|
阿托伐他汀钙杂质O对照品 |
|
|
Atorvastatin Calcium Impurity W Reference Standard
|
阿托伐他汀钙杂质W对照品 |
|
|
Mosapride impurity N-nitrosamine impurity 1
|
莫沙必利杂质亚硝胺杂质1 |
|
|
3-Pyridin-4-ylpentane-2.4-dione
|
3-(4-吡啶基)-2,4-戊二酮 |
103977-47-5 |
|
Methyl Levocamphorsulfonate
|
左旋樟脑磺酸甲酯对照品 |
83603-04-7 |
|
Calcium Leucovorin Impurity I
|
亚叶酸钙杂质I |
3432-99-3 |
|
Impurity A (Trazodone N-oxide)
|
杂质A(曲唑酮N-氧化物) |
|
|
4-Ethoxy-1-(4-pyridyl)-3-buten-2-one
|
4-乙氧基-1-(4-吡啶基)-3-丁烯-2-酮 |
|
|
2-[(1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl]acetic acid methyl ester
|
2-[(1R,5S)-3-乙基双环[3.2.0]庚-3-烯-6-亚基]乙酸甲酯 |
|
|
Safinamide Impurity T
|
沙芬酰胺杂质T |
|
|
2,4-Diamino-6-morpholino-1,3,5-triazine
|
2,4-二胺-6-吗啉基-1,3,5-三嗪 |
2827-42-1 |
|
Piroxicam Impurity B
|
吡罗昔康杂质B |
65897-46-3 |
|
Lamotrigine Impurity C Reference Standard (Impurity A)
|
拉莫三嗪杂质C对照品(杂质A) |
252186-78-0 |
|
Tulathromycin Impurity B
|
泰拉霉素杂质B |
|
|
Omadacycline Impurity 4
|
奥马环素杂质4 |
2272886-37-8 |
|
Tenapanor Impurity 6
|
替纳帕诺杂质 6 |
2200552-25-4 |
|
9,10-Anhydro-8-desacetyl-8-carboxy Dauno
|
9,10-Anhydro-8-desacetyl-8-carboxy Dauno |
|
|
Rivaroxaban iMpurity IV-7
|
利伐沙班杂质IV-7 |
|
|
3-Ethylidene-1,3-dicyclo[3.2.0]heptan-6-one reference substance
|
3-亚乙基二环[3.2.0]庚烷-6-酮对照品 |
|
|
Fasudil Hydrochloride Impurity D
|
盐酸法舒地尔杂质D |
1337967-93-7 |
|
2-amino-5-cyano-6-oxo-1,6-dihydropyridine-3-carboxamide
|
2-氨基-5-氰基-6-氧代-1,6-二氢吡啶-3-酰胺 |
717818-05-8 |
|
Impurity G (hydrochloride)
|
杂质G(盐酸盐) |
4033-27-6 |
|
(1s) - 4,5-dimethoxy-1 - (ethoxycarbonylaminomethyl) - benzocyclobutane
|
(1S)-4,5-二甲氧基-1-[(甲基氨基)甲基]苯并环丁烷盐酸盐杂质D |
869856-10-0 |
|
Finerenone impurity J
|
非奈利酮杂质J |
|
|
H-AEEA-AEEA-AEEA-OH
|
H-AEEA-AEEA-AEEA-OH 对照品 |
|
|
Tenapanor Impurity 19
|
替纳帕诺杂质 19 |
1631730-06-7 |
|
Malate Sunitinib Impurities SM1-4
|
苹果酸舒尼替尼杂质SM1-4 |
2365-44-8 |
|
Enzalutamide Impurity 10269-1206
|
恩扎卢胺杂质10269-1206 |
|
|
Acetic acid illegal forest impurity DFL-Z18
|
醋酸地非法林杂质DFL-Z18 |
|
|
6-Hydroxy-5-nitronaphthylamine reference substance
|
6-羟基-5-亚硝基萘脒对照品 |
|
|
2-Cyanoethyl 2-(2,5-dimethylfuran-3-yl)-2-oxoacetate
|
2-氰乙基2-(2,5-二甲基呋喃-3-基)-2-氧乙酸酯 |
|
|
Atorvastatin Calcium Impurity P Reference Standard
|
阿托伐他汀钙杂质P对照品 |
|
|
Mosapride Impurity 44
|
莫沙必利杂质44 |
|
|
Hydrochloride Juneladron Impurity JNDL-1
|
盐酸决萘达隆杂质JNDL-1 |
141644-91-9 |
|
Granisetron intermediate 1
|
格拉司琼中间体1对照品 |
115660-68-9 |
|
2-Cyano-3-fluorobromobenzyl PHY180161
|
2-氰基-3-氟溴苄PHY180161 |
1261686-95-6 |
|
3-(2,5-Dichloro-4,6-dimethylpyridin-3-yl)-5-(3,4-dimethoxy-5-nitrophenyl)-1,2,4-oxadiazole
|
3-(2,5-二氯-4,6-二甲基吡啶-3-基)-5-(3,4-二甲氧基-5-硝基苯基)-1,2,4-噁二唑 |
2356241-50-2 |
|
2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-isopropoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate
|
2-氰乙基4-(4-氰-2-甲氧基苯基)-5-异丙氧基-2,8-二甲基-1,4-二氢-1,6-萘啶-3-羧酸酯 |
|
|
Methyl 4-bromo-2-methylbenzo[d]oxazole-6-carboxylate
|
4-溴-2-甲基苯并[d]噁唑-6-羧酸甲酯 |
2306321-18-4 |
|
APLZ-IM-F
|
APLZ-IM-F |
|
|
Genotoxic Impurity BY114-2
|
基因毒性杂质BY114-2 |
|
|
Itramod arginine impurity Ⅱ-5
|
伊曲莫德精氨酸杂质Ⅱ-5 |
|
|
Esrabetelol Hydrochloride Intermediate IV
|
盐酸艾司洛尔中间体IV |
|
|
1-[3-Bromo-5-(trifluoromethyl)phenyl]-2,2,2-trifluoroethan-1-one
|
1-(3-溴-5-(三氟甲基)苯基)-2,2,2-三氟乙烷-1-酮 |
1132701-00-8 |
|
Des-Me-SLD: Pipazine, 1-[[3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl
|
Des-Me-SLD:哌嗪,1-[[3-(4,7-二氢-1-甲基-7-氧代-3-丙基-1H-吡唑并[4,3-d]嘧啶-5-基)-4-乙氧基苯基]磺酰基 |
139755-82-1 |
|
2-Nitrosopyridine
|
2-亚硝基吡啶 |
79917-37-6 |
|
Amidotrizoic Acid Impurity B
|
泛影酸钠杂质B |
162193-52-4 |
|
Mirabegron Impurity HD1927-3012
|
米拉贝隆HD1927-3012 |
861337-74-8 |
|
Bumetanide Impurity INT1-G
|
布美他尼杂质INT1-G |
74917-54-7 |
|
Deoxycholic acid ethyl ester reference standard
|
脱氧胆酸乙基酯对照品 |
69519-35-3 |
|
2,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide
|
2,5-二氯-3-(5-(3,4-二羟基-5-硝基苯基)-1,2,4-噁二唑-3-基)-4,6-二甲基吡啶-1-氧化物 |
1402714-31-1 |
|
Benzoic acid, 3,5-dibromo-2-(methylamino)-
|
3,5-二溴-2-甲氨基苯甲酸 |
16524-06-4 |
|
Tenapanor Impurity 23
|
替纳帕诺杂质 23 |
3096071-66-5 |
|
Ceftiofur Furoic Amide
|
呋喃头孢噻呋胺(Ceftiofur Furoic Amide) |
|
|
Mosapride Impurity 38
|
莫沙必利杂质38 |
|
|
Lamotrigine Impurity D Reference Standard (Impurity F)
|
拉莫三嗪杂质D对照品(杂质F) |
252186-79-1 |
|
ethyl 4-hydroxy-3-methoxy-5-nitrobenzoate
|
4-羟基-3-甲氧基-5-硝基甲酸乙酯 |
64095-07-4 |
|
Safinamide Impurity V
|
沙芬酰胺杂质V |
|
|
2-((8R,9S,10R,3S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl propionate
|
2-((8R,9S,10R,3S,14S,17R)-17-羟基-10,13-二甲基-3-氧代-2,3,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊[a]菲-17-基)-2-氧代乙基丙酸 |
95624-09-2 |
|
Norfloxacin Impurity NFSX-2-06
|
诺氟沙星杂质NFSX-2-06 |
70032-16-5 |
|
Benzbromarone Impurity
|
苯溴马隆杂质 |
2518282-93-2 |
|
NFSX-3-04 / Anti-cyclam Complex
|
NFSX-3-04/反环螯合物 |
|
|
N-Nitrosonaphtholone
|
N-亚硝基非萘利酮 |
|
|
Itramod arginine impurity I-3
|
伊曲莫德精氨酸杂质I-3 |
|
|
2-((1R,5S)-3-ethyl-bicyclo[3.2.0]hept-3-en-6-ylmethyl)acetic acid
|
2-((1R,5S)-3-乙基-双环[3.2.0]庚-3-烯-6-基亚基)乙酸 |
|
|
Sarpogrelate iMpurity
|
沙格雷酯杂质 |
|
|
Piperacillin Impurity S
|
哌拉西林杂质S |
|
|
Tenapanor Dihydrochloride
|
盐酸替纳帕诺 |
1234365-97-9 |
|
Ketoprofen Impurity 23
|
酮洛芬杂质23 |
|
|
Isoxazolo[5,4-b]pyridin-3-amine, 5-chloro-4,6-dimethyl-
|
5-氯-4,6-二甲基异噁唑并[5,4-b]吡啶-3-胺 |
893767-99-2 |
|
N-Nitroso Citalopram
|
N-亚硝基去甲基西酞普兰 |
|
|
Malate Sunitinib Impurities A
|
苹果酸舒尼替尼杂质A |
356068-93-4 |
|
Mianserin Hydrochloride Tablets - Impurity IV (1,2,3,4,10,14b-tetrahydro-dibenz[c,f]pyrazino[1,2-a]azepine)
|
盐酸米安色林片-杂质Ⅳ(1,2,3,4,10,14b-六氢二苯并[c,f]吡嗪[1,2-α]氮杂䓬 |
|
|
Dutasteride M2 - Impurity G
|
多替诺雷M2-杂质G |
|
|
Finerenone Impurity RE
|
非奈利酮杂质RE |
|
|
Rosuvastatin Calcium Impurity B Reference Standard
|
瑞舒伐他汀钙杂质B对照品 |
1094100-06-7 |
|
5-bromo-2-methoxy-4,6-dimethylpyridine-3-carbonitrile
|
2-甲氧基-5-氯-4,6-二甲基烟腈 |
91591-66-1 |
|
Ambroxol Cycloimine Impurity
|
盐酸氨溴索环亚胺杂质 |
2088879-81-4 |
|
Norfloxacin Impurity NFSX-2-10
|
诺氟沙星杂质NFSX-2-10 |
106847-40-9 |
|
2-((8R,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetate ethyl ester
|
2-((8R,9S,10R,13S,14S,17R)-17-羟基-10,13-二甲基-3-氧代-2,3,6,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊[a]菲-17-基)-2-氧代乙酸乙酯 |
640-87-9 |
|
Safinamide Impurity M
|
沙芬酰胺杂质M |
|
|
|
磷奈匹坦杂质LPSM1-d |
16540-40-2 |
|
Safinamide Impurity U
|
沙芬酰胺杂质U |
|